|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
affects transport multiple interactions |
ISO EXP |
ABCG2 protein affects the transport of Cimetidine Cimetidine inhibits the reaction [ABCG2 protein results in increased export of bisbenzimide ethoxide trihydrochloride] |
CTD |
PMID:15365089 PMID:15722455 PMID:26907376 |
|
NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661
|
|
G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
multiple interactions |
ISO |
Cimetidine inhibits the reaction [ADH1C protein results in increased oxidation of Ethanol] |
CTD |
PMID:23220590 |
|
NCBI chr 3:137,983,346...137,996,459
Ensembl chr 3:137,966,752...137,996,459
|
|
G |
Adh4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
multiple interactions |
ISO |
Cimetidine inhibits the reaction [ADH4 protein results in increased oxidation of Ethanol] |
CTD |
PMID:23220590 |
|
NCBI chr 3:138,121,217...138,138,444
Ensembl chr 3:138,121,227...138,136,653
|
|
G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
multiple interactions |
ISO |
Cimetidine inhibits the reaction [ADH5 protein results in increased oxidation of S-hydroxymethylglutathione] |
CTD |
PMID:23220590 |
|
NCBI chr 3:138,142,961...138,161,260
Ensembl chr 3:138,148,854...138,161,260
|
|
G |
Adh7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
multiple interactions |
ISO |
Cimetidine inhibits the reaction [ADH7 protein results in increased oxidation of Ethanol] |
CTD |
PMID:23220590 |
|
NCBI chr 3:137,903,828...137,937,803
Ensembl chr 3:137,923,521...137,939,143
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
multiple interactions |
ISO |
Cimetidine promotes the reaction [Metformin results in decreased expression of ADIPOQ mRNA] |
CTD |
PMID:20956498 |
|
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
|
|
G |
Ahr |
aryl-hydrocarbon receptor |
affects expression multiple interactions |
ISO |
Cimetidine affects the expression of AHR protein [Monocrotophos co-treated with Cimetidine] results in increased expression of AHR protein |
CTD |
PMID:22733800 |
|
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase family 1, subfamily A1 |
multiple interactions |
ISO |
Cimetidine inhibits the reaction [ALDH1A1 protein results in increased oxidation of Acetaldehyde] |
CTD |
PMID:23220590 |
|
NCBI chr19:20,469,947...20,620,827
Ensembl chr19:20,470,079...20,620,829
|
|
G |
Aldh3a1 |
aldehyde dehydrogenase family 3, subfamily A1 |
multiple interactions |
ISO |
Cimetidine inhibits the reaction [ALDH3A1 protein results in increased oxidation of benzaldehyde] |
CTD |
PMID:23220590 |
|
NCBI chr11:61,099,336...61,109,244
Ensembl chr11:61,098,363...61,109,247
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases activity |
ISO |
Cimetidine results in increased activity of APAF1 protein |
CTD |
PMID:17273750 |
|
NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632
|
|
G |
Ar |
androgen receptor |
multiple interactions decreases expression |
EXP ISO |
Cimetidine inhibits the reaction [Dihydrotestosterone binds to AR protein] Cimetidine results in decreased expression of AR protein |
CTD |
PMID:6835285 PMID:26021711 |
|
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
|
|
G |
Bax |
BCL2-associated X protein |
increases expression multiple interactions |
ISO EXP |
Cimetidine results in increased expression of BAX protein Cimetidine inhibits the reaction [Ethanol results in increased expression of BAX protein] |
CTD |
PMID:20127008 PMID:27983966 |
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
decreases expression multiple interactions |
ISO EXP |
Cimetidine results in decreased expression of BCL2 protein Cimetidine inhibits the reaction [Ethanol results in decreased expression of BCL2 protein] |
CTD |
PMID:20127008 PMID:27983966 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Casp1 |
caspase 1 |
increases activity multiple interactions |
ISO |
Cimetidine results in increased activity of CASP1 protein CASP1 protein affects the reaction [Cimetidine results in increased expression of IL18 protein] |
CTD |
PMID:16723495 |
|
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
|
|
G |
Casp12 |
caspase 12 |
multiple interactions |
EXP |
Cimetidine inhibits the reaction [Ethanol results in increased expression of CASP12 protein] |
CTD |
PMID:27983966 |
|
NCBI chr 9:5,345,419...5,373,034
Ensembl chr 9:5,345,430...5,373,032
|
|
G |
Casp3 |
caspase 3 |
increases activity increases expression multiple interactions |
ISO EXP |
Cimetidine results in increased activity of CASP3 protein Cimetidine results in increased expression of CASP3 protein Cimetidine inhibits the reaction [Ethanol results in increased expression of CASP3 protein] |
CTD |
PMID:17273750 PMID:20127008 PMID:26021711 PMID:27983966 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp7 |
caspase 7 |
increases activity |
ISO |
Cimetidine results in increased activity of CASP7 protein |
CTD |
PMID:17273750 |
|
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
|
|
G |
Casp8 |
caspase 8 |
increases activity |
ISO |
Cimetidine results in increased activity of CASP8 protein |
CTD |
PMID:17273750 PMID:20127008 |
|
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
Cimetidine results in increased activity of CASP9 protein |
CTD |
PMID:17273750 PMID:20127008 |
|
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
Cimetidine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein] |
CTD |
PMID:12107048 |
|
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Cd14 |
CD14 antigen |
decreases expression |
ISO |
Cimetidine results in decreased expression of CD14 protein |
CTD |
PMID:11556524 |
|
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
|
|
G |
Cst3 |
cystatin C |
multiple interactions |
ISO |
Cimetidine inhibits the reaction [Cisplatin results in increased expression of CST3] |
CTD |
PMID:22525860 |
|
NCBI chr 2:148,713,642...148,717,432
Ensembl chr 2:148,713,642...148,717,612
|
|
G |
Ctsd |
cathepsin D |
decreases activity |
ISO |
Cimetidine results in decreased activity of CTSD protein |
CTD |
PMID:12903910 |
|
NCBI chr 7:141,929,647...141,941,564
Ensembl chr 7:141,929,648...141,941,775
|
|
G |
Ctsl |
cathepsin L |
decreases activity |
ISO |
Cimetidine results in decreased activity of CTSL protein |
CTD |
PMID:12903910 |
|
NCBI chr13:64,509,704...64,518,586
Ensembl chr13:64,507,151...64,518,704
|
|
G |
Cxcl15 |
C-X-C motif chemokine ligand 15 |
multiple interactions |
ISO |
Cimetidine inhibits the reaction [IL1B protein results in increased secretion of CXCL8 protein]; Cimetidine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CXCL8 protein] |
CTD |
PMID:12065299 PMID:12107048 |
|
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions decreases activity decreases expression |
EXP ISO |
Cimetidine inhibits the reaction [Cocaine results in increased expression of CYP1A1 protein] Cimetidine results in decreased activity of CYP1A1 protein [Monocrotophos co-treated with Cimetidine] results in increased expression of CYP1A1 protein Cimetidine results in decreased expression of CYP1A1 protein |
CTD |
PMID:11856816 PMID:22733800 |
|
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions decreases activity |
ISO |
Cimetidine inhibits the reaction [CYP1A2 protein results in increased metabolism of Tacrine]; NADP promotes the reaction [Cimetidine inhibits the reaction [CYP1A2 protein results in increased metabolism of Tacrine]]; styrofoam analog promotes the reaction [Cimetidine results in decreased activity of CYP1A2 protein] |
CTD |
PMID:7946932 PMID:19909766 PMID:31863871 |
|
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
|
|
G |
Cyp2b10 |
cytochrome P450, family 2, subfamily b, polypeptide 10 |
decreases activity multiple interactions decreases expression |
ISO |
Cimetidine results in decreased activity of CYP2B6 protein [Monocrotophos co-treated with Cimetidine] results in increased expression of CYP2B6 protein Cimetidine results in decreased expression of CYP2B6 protein |
CTD |
PMID:22733800 |
|
NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
|
|
G |
Cyp2c52-ps |
cytochrome P450, family 2, subfamily c, polypeptide 52, pseudogene |
multiple interactions |
ISO |
Cimetidine inhibits the reaction [CYP2C11 protein results in increased glutathionylation of lamotrigine] |
CTD |
PMID:19961160 |
|
NCBI chr19:38,965,106...38,992,071
Ensembl chr19:38,965,091...38,991,733
|
|
G |
Cyp2c65 |
cytochrome P450, family 2, subfamily c, polypeptide 65 |
decreases activity multiple interactions |
ISO |
Cimetidine results in decreased activity of CYP2C9 protein styrofoam analog promotes the reaction [Cimetidine results in decreased activity of CYP2C9 protein] |
CTD |
PMID:19909766 |
|
NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
|
|
G |
Cyp2d22 |
cytochrome P450, family 2, subfamily d, polypeptide 22 |
multiple interactions decreases activity |
ISO |
Cimetidine inhibits the reaction [CYP2D6 protein results in increased metabolism of Dextromethorphan] Cimetidine results in decreased activity of CYP2D6 protein styrofoam analog promotes the reaction [Cimetidine results in decreased activity of CYP2D6 protein] |
CTD |
PMID:17651725 PMID:19909766 |
|
NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases expression multiple interactions |
ISO |
Cimetidine results in decreased expression of CYP2E1 protein [Monocrotophos co-treated with Cimetidine] results in increased expression of CYP2E1 protein |
CTD |
PMID:22733800 |
|
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
|
|
G |
Cyp2j9 |
cytochrome P450, family 2, subfamily j, polypeptide 9 |
multiple interactions |
EXP |
Cimetidine inhibits the reaction [Cocaine results in increased expression of CYP2J2 protein] |
CTD |
PMID:11856816 |
|
NCBI chr 4:96,456,661...96,480,748
Ensembl chr 4:96,456,666...96,479,815
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions |
EXP |
Cimetidine inhibits the reaction [Ethanol results in increased expression of DDIT3 protein] |
CTD |
PMID:27983966 |
|
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
ISO EXP |
Cimetidine inhibits the reaction [EGFR protein results in increased phosphorylation of EGFR protein] [Cimetidine results in decreased abundance of Cyclic AMP] inhibits the reaction [EGFR protein results in increased phosphorylation of EGFR protein] |
CTD |
PMID:17295779 |
|
NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
|
|
G |
Fshb |
follicle stimulating hormone beta |
affects expression |
ISO |
Cimetidine affects the expression of FSHB protein |
CTD |
PMID:435711 |
|
NCBI chr 2:106,886,331...106,889,996
Ensembl chr 2:106,886,485...106,890,001
|
|
G |
Gast |
gastrin |
affects expression |
ISO |
Cimetidine affects the expression of GAST protein |
CTD |
PMID:12503773 |
|
NCBI chr11:100,225,233...100,227,823
Ensembl chr11:100,225,233...100,227,822
|
|
G |
Gstp1 |
glutathione S-transferase, pi 1 |
affects expression multiple interactions |
ISO |
Cimetidine affects the expression of GSTP1 protein [Monocrotophos co-treated with Cimetidine] results in increased expression of GSTP1 protein |
CTD |
PMID:22733800 |
|
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
ISO |
[piperine co-treated with Cimetidine co-treated with Pyruvates] inhibits the reaction [Puromycin Aminonucleoside results in increased expression of HMOX1 protein] |
CTD |
PMID:12806184 |
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Hrh1 |
histamine receptor H1 |
multiple interactions |
EXP |
Cimetidine inhibits the reaction [HRH1 results in decreased susceptibility to Morphine] |
CTD |
PMID:14569158 |
|
NCBI chr 6:114,374,897...114,459,432
Ensembl chr 6:114,374,897...114,460,257
|
|
G |
Hrh2 |
histamine receptor H2 |
multiple interactions increases expression decreases activity |
ISO EXP |
[Cimetidine binds to and results in decreased activity of HRH2 protein] results in decreased susceptibility to [Histamine co-treated with [Oxygen deficiency co-treated with Oxygen]]; [Cimetidine binds to and results in decreased activity of HRH2 protein] which affects the susceptibility to Metformin; [Cimetidine binds to and results in decreased activity of HRH2 protein] which results in decreased abundance of Cyclic AMP; Burimamide inhibits the reaction [[Cyclic AMP binds to and results in decreased activity of HRH2 protein] which results in decreased abundance of Cimetidine]; Cimetidine binds to and results in decreased activity of HRH2 protein; Cimetidine binds to and results in increased activity of HRH2 protein; Cimetidine inhibits the reaction [HRH2 protein promotes the reaction [Histamine results in increased expression of IL16 protein]] Cimetidine results in increased expression of HRH2 protein Cimetidine binds to and results in increased activity of HRH2 protein; Cimetidine inhibits the reaction [HRH2 results in decreased susceptibility to Morphine]; HRH2 protein affects the reaction [Cimetidine results in increased expression of IL18 protein] [Cimetidine binds to and results in decreased activity of HRH2 protein] which results in decreased susceptibility to clobenpropit; Cimetidine binds to and results in decreased activity of HRH2 protein; Cimetidine inhibits the reaction [[Histamine binds to and results in increased activity of HRH2 protein] which results in decreased susceptibility to Scopolamine] Cimetidine results in decreased activity of HRH2 protein |
CTD |
PMID:1912125 PMID:2461127 PMID:6522242 PMID:9681472 PMID:12235264 PMID:14569158 PMID:15961859 PMID:16488453 PMID:16632449 PMID:16723495 PMID:19215234 PMID:21276809 PMID:22926047 More...
|
|
NCBI chr13:54,345,990...54,390,201
Ensembl chr13:54,346,148...54,390,199
|
|
G |
Hspa5 |
heat shock protein 5 |
multiple interactions |
EXP |
Cimetidine inhibits the reaction [Ethanol results in increased expression of HSPA5 protein] |
CTD |
PMID:27983966 |
|
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
decreases expression |
ISO |
Cimetidine results in decreased expression of ICAM1 protein |
CTD |
PMID:17189874 |
|
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
|
|
G |
Ifng |
interferon gamma |
multiple interactions increases expression |
ISO |
Cimetidine inhibits the reaction [Histamine inhibits the reaction [Lipopolysaccharides results in increased expression of IFNG protein]] Cimetidine results in increased expression of IFNG mRNA; Cimetidine results in increased expression of IFNG protein |
CTD |
PMID:10569698 |
|
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
|
|
G |
Il16 |
interleukin 16 |
multiple interactions |
ISO |
Cimetidine inhibits the reaction [HRH2 protein promotes the reaction [Histamine results in increased expression of IL16 protein]] |
CTD |
PMID:12235264 |
|
NCBI chr 7:83,292,027...83,395,479
Ensembl chr 7:83,292,033...83,394,934
|
|
G |
Il18 |
interleukin 18 |
multiple interactions increases expression |
ISO EXP |
CASP1 protein affects the reaction [Cimetidine results in increased expression of IL18 protein]; Famotidine inhibits the reaction [Cimetidine results in increased expression of IL18 protein]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Cimetidine results in increased expression of IL18 protein]; Ranitidine inhibits the reaction [Cimetidine results in increased expression of IL18 protein] HRH2 protein affects the reaction [Cimetidine results in increased expression of IL18 protein] |
CTD |
PMID:16723495 |
|
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
Cimetidine inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]]; Cimetidine inhibits the reaction [IL1B protein results in increased secretion of CXCL8 protein] |
CTD |
PMID:12065299 |
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Itga4 |
integrin alpha 4 |
decreases expression |
ISO |
Cimetidine results in decreased expression of ITGA4 protein |
CTD |
PMID:11556524 |
|
NCBI chr 2:79,084,767...79,163,458
Ensembl chr 2:79,085,770...79,163,467
|
|
G |
Itgax |
integrin alpha X |
decreases expression |
ISO |
Cimetidine results in decreased expression of ITGAX protein |
CTD |
PMID:11556524 |
|
NCBI chr 7:127,728,697...127,749,829
Ensembl chr 7:127,728,719...127,749,829
|
|
G |
Lrp1 |
low density lipoprotein receptor-related protein 1 |
decreases expression |
ISO |
Cimetidine results in decreased expression of LRP1 protein |
CTD |
PMID:11556524 |
|
NCBI chr10:127,374,026...127,457,158
Ensembl chr10:127,374,030...127,457,017
|
|
G |
Ncam1 |
neural cell adhesion molecule 1 |
decreases expression |
ISO |
Cimetidine results in decreased expression of NCAM mRNA; Cimetidine results in decreased expression of NCAM protein |
CTD |
PMID:17273750 |
|
NCBI chr 9:49,413,434...49,710,909
Ensembl chr 9:49,413,436...49,710,225
|
|
G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
multiple interactions |
ISO |
Cimetidine inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]]; Cimetidine inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of NFKB1 protein] |
CTD |
PMID:12065299 PMID:12107048 |
|
NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
decreases expression multiple interactions |
ISO |
Cimetidine results in decreased expression of NR1I2 protein [Monocrotophos co-treated with Cimetidine] results in increased expression of NR1I2 protein |
CTD |
PMID:22733800 |
|
NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
decreases expression multiple interactions |
ISO |
Cimetidine results in decreased expression of NR1I3 protein [Monocrotophos co-treated with Cimetidine] results in increased expression of NR1I3 protein |
CTD |
PMID:22733800 |
|
NCBI chr 1:171,041,503...171,046,414
Ensembl chr 1:171,041,539...171,048,270
|
|
G |
Ntf3 |
neurotrophin 3 |
multiple interactions |
ISO |
Cimetidine inhibits the reaction [Histamine results in increased expression of NTF3 protein] |
CTD |
PMID:21276809 |
|
NCBI chr 6:126,078,375...126,143,703
Ensembl chr 6:126,078,375...126,143,873
|
|
G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
multiple interactions |
ISO |
Cimetidine inhibits the reaction [Histamine results in increased expression of PDE4B mRNA] |
CTD |
PMID:11131300 |
|
NCBI chr 4:101,944,529...102,464,459
Ensembl chr 4:101,944,740...102,464,456
|
|
G |
Prl |
prolactin |
affects expression |
ISO |
Cimetidine affects the expression of PRL protein |
CTD |
PMID:435711 PMID:9037573 |
|
NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188
|
|
G |
Prok1 |
prokineticin 1 |
decreases expression |
ISO |
Cimetidine results in decreased expression of PROK1 protein |
CTD |
PMID:26021711 |
|
NCBI chr 3:107,139,232...107,147,023
Ensembl chr 3:107,140,113...107,147,023
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
multiple interactions |
ISO EXP |
Cimetidine inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]]; Cimetidine inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of RELA protein] Cimetidine inhibits the reaction [Ethanol results in increased expression of RELA protein] |
CTD |
PMID:12065299 PMID:12107048 PMID:24300194 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Selp |
selectin, platelet |
decreases expression |
ISO |
Cimetidine results in decreased expression of SELP protein |
CTD |
PMID:17189874 |
|
NCBI chr 1:163,942,833...163,977,595
Ensembl chr 1:163,942,833...163,977,595
|
|
G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
increases uptake multiple interactions |
ISO |
SLC22A1 protein results in increased uptake of Cimetidine Cimetidine inhibits the reaction [SLC22A1 protein results in increased uptake of Ethidium] |
CTD |
PMID:16006492 PMID:19357179 |
|
NCBI chr17:12,867,761...12,894,725
Ensembl chr17:12,867,756...12,894,716
|
|
G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
multiple interactions increases uptake decreases response to substance increases transport |
ISO |
1-Methyl-4-phenylpyridinium inhibits the reaction [SLC22A2 protein results in increased uptake of Cimetidine]; Cimetidine inhibits the reaction [SLC22A2 protein affects the transport of Tetraethylammonium]; Cimetidine inhibits the reaction [SLC22A2 protein polymorphism results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]; Cimetidine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]; Cimetidine inhibits the reaction [SLC22A2 protein results in increased uptake of Ethidium]; p-Aminohippuric Acid inhibits the reaction [SLC22A2 protein results in increased uptake of Cimetidine] SLC22A2 gene polymorphism results in decreased susceptibility to Cimetidine SLC22A2 protein results in increased transport of Cimetidine |
CTD |
PMID:15496291 PMID:16006492 PMID:18230276 PMID:19357179 PMID:21599003 PMID:22525860 More...
|
|
NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
|
|
G |
Slc22a27 |
solute carrier family 22, member 27 |
multiple interactions increases transport |
EXP |
Cimetidine inhibits the reaction [SLC22A27 protein alternative form results in increased uptake of Carnitine] SLC22A27 protein alternative form results in increased transport of Cimetidine |
CTD |
PMID:20332632 |
|
NCBI chr19:7,841,753...7,943,899
Ensembl chr19:7,841,753...7,943,392
|
|
G |
Slc22a3 |
solute carrier family 22 (organic cation transporter), member 3 |
multiple interactions increases transport |
ISO EXP |
Cimetidine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Cimetidine inhibits the reaction [SLC22A3 protein results in increased uptake of Ethidium]; Cimetidine inhibits the reaction [SLC22A3 protein results in increased uptake of Metformin] SLC22A3 protein results in increased transport of Cimetidine Cimetidine inhibits the reaction [SLC22A3 protein results in increased uptake of Tetraethylammonium] |
CTD |
PMID:10966924 PMID:18253050 PMID:19357179 PMID:21697722 |
|
NCBI chr17:12,638,859...12,726,591
Ensembl chr17:12,637,847...12,726,591
|
|
G |
Slc22a6 |
solute carrier family 22 (organic anion transporter), member 6 |
multiple interactions increases uptake |
ISO |
1-Methyl-4-phenylpyridinium inhibits the reaction [SLC22A6 protein results in increased uptake of Cimetidine]; Cimetidine inhibits the reaction [SLC22A6 protein affects the transport of p-Aminohippuric Acid]; p-Aminohippuric Acid inhibits the reaction [SLC22A6 protein results in increased uptake of Cimetidine] |
CTD |
PMID:15496291 PMID:16006492 PMID:16098483 |
|
NCBI chr19:8,595,360...8,605,663
Ensembl chr19:8,595,403...8,605,663
|
|
G |
Slc22a7 |
solute carrier family 22 (organic anion transporter), member 7 |
increases uptake multiple interactions |
ISO EXP |
SLC22A7 protein results in increased uptake of Cimetidine Cimetidine inhibits the reaction [SLC22A7 protein results in increased uptake of Glutarates] |
CTD |
PMID:12065749 PMID:16006492 |
|
NCBI chr17:46,743,111...46,749,403
Ensembl chr17:46,743,109...46,749,383
|
|
G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
multiple interactions affects transport increases uptake |
ISO EXP |
Cimetidine inhibits the reaction [SLC22A8 protein affects the transport of estrone sulfate]; Probenecid inhibits the reaction [SLC22A8 protein affects the transport of Cimetidine] estradiol-17 beta-glucuronide inhibits the reaction [SLC22A8 protein results in increased uptake of Cimetidine]; estrone sulfate inhibits the reaction [SLC22A8 protein results in increased uptake of Cimetidine]; Famotidine inhibits the reaction [SLC22A8 protein results in increased uptake of Cimetidine]; p-Aminohippuric Acid inhibits the reaction [SLC22A8 protein results in increased uptake of Cimetidine]; Penicillin G inhibits the reaction [SLC22A8 protein results in increased uptake of Cimetidine]; Probenecid inhibits the reaction [SLC22A8 protein affects the transport of Cimetidine]; Probenecid promotes the reaction [SLC22A8 protein results in increased uptake of Cimetidine]; Ranitidine inhibits the reaction [SLC22A8 protein results in increased uptake of Cimetidine] Cimetidine inhibits the reaction [SLC22A8 protein results in increased uptake of p-Aminohippuric Acid] |
CTD |
PMID:10224140 PMID:11306713 PMID:15100168 PMID:15319347 PMID:15496291 PMID:16006492 PMID:16098483 More...
|
|
NCBI chr19:8,568,576...8,589,199
Ensembl chr19:8,568,618...8,589,199
|
|
G |
Slc47a1 |
solute carrier family 47, member 1 |
affects transport decreases activity multiple interactions |
ISO EXP |
SLC47A1 protein affects the transport of Cimetidine Cimetidine results in decreased activity of SLC47A1 protein Cimetidine inhibits the reaction [SLC47A1 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]; Cimetidine inhibits the reaction [SLC47A1 protein results in increased uptake of Cadmium] |
CTD |
PMID:16928787 PMID:21599003 PMID:27871888 |
|
NCBI chr11:61,234,226...61,269,668
Ensembl chr11:61,234,227...61,269,171
|
|
G |
Slc47a2 |
solute carrier family 47, member 2 |
multiple interactions |
ISO |
Cimetidine inhibits the reaction [SLC47A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]; Cimetidine inhibits the reaction [SLC47A2 protein results in increased uptake of Cadmium] |
CTD |
PMID:21599003 PMID:27871888 |
|
NCBI chr11:61,192,453...61,233,686
Ensembl chr11:61,192,457...61,233,686
|
|
G |
Slc9a3 |
solute carrier family 9 (sodium/hydrogen exchanger), member 3 |
multiple interactions |
ISO |
[piperine co-treated with Cimetidine co-treated with Pyruvates] inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of SLC9A3 protein] |
CTD |
PMID:12806184 |
|
NCBI chr13:74,234,374...74,317,561
Ensembl chr13:74,269,576...74,317,561
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO EXP |
Cimetidine inhibits the reaction [Dimaprit inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]] Cimetidine inhibits the reaction [Cocaine results in increased expression of TNF protein] |
CTD |
PMID:9088875 PMID:11856816 |
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|